Axogen, Inc. Reports 2023 First Quarter Financial Results
May 09, 2023 07:00 ET
|
Axogen, Inc.
ALACHUA, Fla. and TAMPA, Fla., May 09, 2023 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for peripheral nerve injuries,...
Axogen, Inc. to report first quarter 2023 financial results and host conference call on May 9, 2023
April 18, 2023 16:05 ET
|
Axogen, Inc.
ALACHUA, Fla. and TAMPA, Fla., April 18, 2023 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for peripheral nerve...
Axogen, Inc Reports 2022 Fourth Quarter and Full-Year Financial Results
March 14, 2023 07:00 ET
|
Axogen, Inc.
ALACHUA, Fla. and TAMPA, Fla., March 14, 2023 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for peripheral nerve...
Axogen, Inc. to report fourth quarter 2022 financial results and host conference call on March 14, 2023
March 02, 2023 16:00 ET
|
Axogen, Inc.
ALACHUA, Fla. and TAMPA, Fla., March 02, 2023 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for peripheral nerve...
Axogen, Inc. Appoints Jens Schroeder Kemp as Chief Marketing Officer
February 13, 2023 07:00 ET
|
Axogen, Inc.
ALACHUA, Fla. and TAMPA, Fla., Feb. 13, 2023 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for peripheral nerve injuries,...
Axogen Reports Preliminary Unaudited Revenue for Fourth Quarter and Full-Year 2022
January 09, 2023 07:00 ET
|
Axogen, Inc.
ALACHUA, Fla. and TAMPA, Fla., Jan. 09, 2023 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for peripheral nerve injuries,...
DEADLINE MONDAY: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against AxoGen, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
March 08, 2019 21:30 ET
|
Schall Law
LOS ANGELES, March 08, 2019 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against AxoGen, Inc. (“AxoGen” or...
AXGN REMINDER: Zhang Investor Law Reminds Investors of the March 11 Deadline in Securities Class Action Lawsuit Against AxoGen, Inc. – AXGN
March 04, 2019 16:18 ET
|
Zhang Investor Law P.C.
NEW YORK, March 04, 2019 (GLOBE NEWSWIRE) -- Zhang Investor Law announces the filing of a class action lawsuit on behalf of shareholders who bought shares of AxoGen, Inc. (NASDAQ: AXGN): (1)...
SHAREHOLDER ALERT: Pawar Law Group Announces a Securities Class Action Lawsuit Against AxoGen, Inc. – AXGN
March 01, 2019 16:07 ET
|
Pawar Law Group
NEW YORK, March 01, 2019 (GLOBE NEWSWIRE) -- Pawar Law Group announces that a class action lawsuit has been filed on behalf of shareholders who purchased shares of AxoGen, Inc. (NASDAQ: AXGN): (1)...
AXGN ALERT: Zhang Investor Law Announces the Filing of a Securities Class Action Lawsuit Against AxoGen, Inc. – AXGN
February 21, 2019 15:32 ET
|
Zhang Investor Law P.C.
NEW YORK, Feb. 21, 2019 (GLOBE NEWSWIRE) -- Zhang Investor Law announces the filing of a class action lawsuit on behalf of shareholders who bought shares of AxoGen, Inc. (NASDAQ: AXGN): (1) pursuant...